225 related articles for article (PubMed ID: 23355677)
21. Ectrodactyly-ectodermal dysplasia-cleft syndrome (EEC syndrome) with a developmental delay caused by R304W mutation in the tp63 gene.
Gawrych E; Bińczak-Kuleta A; Janiszewska-Olszowska J; Ciechanowicz A
Ann Acad Med Stetin; 2013; 59(1):11-4. PubMed ID: 24734328
[TBL] [Abstract][Full Text] [Related]
22. Amino-terminal residues of ΔNp63, mutated in ectodermal dysplasia, are required for its transcriptional activity.
Lena AM; Duca S; Novelli F; Melino S; Annicchiarico-Petruzzelli M; Melino G; Candi E
Biochem Biophys Res Commun; 2015 Nov; 467(2):434-40. PubMed ID: 26408908
[TBL] [Abstract][Full Text] [Related]
23. p63-associated disorders.
Rinne T; Brunner HG; van Bokhoven H
Cell Cycle; 2007 Feb; 6(3):262-8. PubMed ID: 17224651
[TBL] [Abstract][Full Text] [Related]
24. Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome.
Kennedy DP; Chandler JW; McCulley JP
Cont Lens Anterior Eye; 2015 Jun; 38(3):228-31. PubMed ID: 25769661
[TBL] [Abstract][Full Text] [Related]
25. Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene.
Wei J; Xue Y; Wu L; Ma J; Yi X; Zhang J; Lu B; Li C; Shi D; Shi S; Feng X; Cai T
PLoS One; 2012; 7(5):e35337. PubMed ID: 22574117
[TBL] [Abstract][Full Text] [Related]
26. Infrared meibography and molecular assessment of p63 gene mutations in a Mexican patient with EEC syndrome.
Garza-Leon M; León-Cachón RBR; Villafuerte-de la Cruz R; Martínez-Treviño DA
Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):562-566. PubMed ID: 30025988
[TBL] [Abstract][Full Text] [Related]
27. Ectodermal dysplasias: the p63 tail.
Tadini G; Santagada F; Brena M; Pezzani L; Nannini P
G Ital Dermatol Venereol; 2013 Feb; 148(1):53-8. PubMed ID: 23407076
[TBL] [Abstract][Full Text] [Related]
28. ADULT syndrome caused by a mutation previously associated with EEC syndrome.
Avitan-Hersh E; Indelman M; Bergman R; Sprecher E
Pediatr Dermatol; 2010; 27(6):643-5. PubMed ID: 21078104
[TBL] [Abstract][Full Text] [Related]
29. Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.
Chung J; Grant RI; Kaplan DR; Irwin MS
J Biol Chem; 2011 Nov; 286(47):40671-80. PubMed ID: 21965674
[TBL] [Abstract][Full Text] [Related]
30. p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes.
Qu J; Yi G; Zhou H
Epigenetics Chromatin; 2019 Jun; 12(1):31. PubMed ID: 31164150
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
Testoni B; Mantovani R
Nucleic Acids Res; 2006; 34(3):928-38. PubMed ID: 16473849
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts.
Barrow LL; van Bokhoven H; Daack-Hirsch S; Andersen T; van Beersum SE; Gorlin R; Murray JC
J Med Genet; 2002 Aug; 39(8):559-66. PubMed ID: 12161593
[TBL] [Abstract][Full Text] [Related]
33. Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome.
Julapalli MR; Scher RK; Sybert VP; Siegfried EC; Bree AF
Am J Med Genet A; 2009 Sep; 149A(9):1900-6. PubMed ID: 19681128
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic analysis of Arg227 mutations of TP63 with emphasis on dental phenotype and micturition difficulties in EEC syndrome.
Sripathomsawat W; Tanpaiboon P; Heering J; Dötsch V; Hennekam RC; Kantaputra P
Am J Med Genet A; 2011 Jan; 155A(1):228-32. PubMed ID: 21204238
[No Abstract] [Full Text] [Related]
35. The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes.
Kirschner RD; Rother K; Müller GA; Engeland K
Cell Cycle; 2010 Jun; 9(11):2177-88. PubMed ID: 20543567
[TBL] [Abstract][Full Text] [Related]
36. Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.
Koster MI; Dinella J; Chen J; O'Shea C; Koch PJ
Cell Commun Adhes; 2014 Feb; 21(1):55-63. PubMed ID: 24460201
[TBL] [Abstract][Full Text] [Related]
37. Development of an allele-specific real-time PCR assay for discrimination and quantification of p63 R279H mutation in EEC syndrome.
Barbaro V; Confalonieri L; Vallini I; Ferrari S; Ponzin D; Mantero G; Willoughby CE; Parekh M; Di Iorio E
J Mol Diagn; 2012 Jan; 14(1):38-45. PubMed ID: 22056627
[TBL] [Abstract][Full Text] [Related]
38. Ankyloblepharon-ectodermal dysplasia-clefting syndrome: a novel p63 mutation associated with generalized neonatal erosions.
Sawardekar SS; Zaenglein AL
Pediatr Dermatol; 2011; 28(3):313-7. PubMed ID: 20738799
[TBL] [Abstract][Full Text] [Related]
39. Innovative Therapeutic Approaches for the Treatment of the Ocular Morbidities in Patients with EEC Syndrome.
Barbaro V; Bonelli F; Ferrari S; La Vella G; Di Iorio E
Cells; 2023 Feb; 12(3):. PubMed ID: 36766837
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects.
Lo Iacono N; Mantero S; Chiarelli A; Garcia E; Mills AA; Morasso MI; Costanzo A; Levi G; Guerrini L; Merlo GR
Development; 2008 Apr; 135(7):1377-88. PubMed ID: 18326838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
